205 related articles for article (PubMed ID: 10554035)
1. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
Pack SD; Zbar B; Pak E; Ault DO; Humphrey JS; Pham T; Hurley K; Weil RJ; Park WS; Kuzmin I; Stolle C; Glenn G; Liotta LA; Lerman MI; Klausner RD; Linehan WM; Zhuang Z
Cancer Res; 1999 Nov; 59(21):5560-4. PubMed ID: 10554035
[TBL] [Abstract][Full Text] [Related]
2. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
3. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
[TBL] [Abstract][Full Text] [Related]
4. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
5. Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.
Huang JS; Huang CJ; Chen SK; Chien CC; Chen CW; Lin CM
Eur J Clin Invest; 2007 Jun; 37(6):492-500. PubMed ID: 17537157
[TBL] [Abstract][Full Text] [Related]
6. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype.
Wait SD; Vortmeyer AO; Lonser RR; Chang DT; Finn MA; Bhowmick DA; Pack SD; Oldfield EH; Zhuang Z
Ann Neurol; 2004 Feb; 55(2):236-40. PubMed ID: 14755727
[TBL] [Abstract][Full Text] [Related]
12. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
13. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
Richard S;
Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
15. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
16. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
Hes FJ; van der Luijt RB
Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
[TBL] [Abstract][Full Text] [Related]
18. Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.
Sgambati MT; Stolle C; Choyke PL; Walther MM; Zbar B; Linehan WM; Glenn GM
Am J Hum Genet; 2000 Jan; 66(1):84-91. PubMed ID: 10631138
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of von Hippel-Lindau disease.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; van den Ouweland AM; Majoor-Krakauer DF; Lolkema MP; van Brussel A; Voest EE; Giles RH
Hum Mutat; 2010 May; 31(5):521-37. PubMed ID: 20151405
[TBL] [Abstract][Full Text] [Related]
20. [Von Hippel-Lindau disease and molecular genetic diagnosis].
Jensen AM; Bisgaard ML
Ugeskr Laeger; 1999 Feb; 161(7):959-61. PubMed ID: 10051806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
